// App-Quantinova.ai

: Genomic Sequencing Reveals Complex and Actionable Molecular Profiles across Hematologic Malignancies

Researchers

Presenter

  • Natalie Galanina

Principal Investigators

  • Catriona Jamieson

  • Razelle Kurzrock

Medical Centers

  • Division of Hematolgy/Oncology, University of Chicago, La Jolla, CA

  • Division of Regenerative Medicine, University of California San Diego, La Jolla, CA

  • Department of Hematology/Oncology, University of California, La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Chronic Lymphocytic Leukemia

  • Myeloid neoplasms

  • Hematological malignancies

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Solid malignancies

  • Lymphomas

Biomarkers

  • Programmed death-ligand 1

  • DNA methyltransferase 3 alpha

  • Histone-lysine N-methyltransferase 2A

  • KRAS proto-oncogene, GTPase

  • Tet methylcytosine dioxygenase 2

  • Tumor protein p53

  • Tumor mutational burden

Drug/Treatment

  • Methadone hydrochloride

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved